Pharmacia & Upjohn's turnaround is real: new CEO, new products help overcome problems
Article Abstract:
After being formed by the merger of Pharmacia AB and Upjohn Co. in 1995, Pharmacia & Upjohn Inc. saw its earnings and share price struggle. This was result of the company's culture conflicts and mistakes. New Chief Executive Officer Fred Hassan said in 1997 that Pharmacia and Upjohn would work to post double-digit growth in earnings for the second-half of 1998. Analysts and investors expressed doubts over Mr. Hassan's statement. However, Pharmacia & Upjohn posted improved earnings for the third-quarter of 1998. A 35% rise in US pharmaceutical sales led to the company's improved profits and revenues.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
Pfizer hopes to launch three drugs next year
Article Abstract:
Pfizer Inc., a manufacturer of pharmaceutical preparations, disclosed plans to introduce in 1999 three new pharmaceuticals for the treatment of arthritis, disorders in heart rhythm and migraine headaches. Pfizer also announced its plans to launch in the year 2000 a new anti-psychotic pharmaceutical preparation. The company cited that from the early part of the 1990s, the productivity of its research initiatives have sharply increased, as shown by its average new-product launching rate of one new product annually.
Comment:
Plans to introduce in 1999 three new pharmaceuticals for treatment of arthritis, disorders in heart rhythm & migraine headaches
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
Emergency contraceptive kit wins U.S. regulatory approval
Article Abstract:
An emergency contraceptive kit that enables women to prevent pregnancies has won the approval of the US Food and Drug Administration. The kit, manufactured by Gynetics Inc., can prevent pregnancies for up to three days after unprotected sexual interaction. A prescription will be required for the kit. The kit will include four birth-control pills, a pregnancy test, and a information booklet. The kit's total cost will approximately be $20.
Comment:
Emergency contraceptive kit that enables women to prevent pregnancies wins approval of the US Food and Drug Administration
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: The German market for fast food: emerging product sectors: new products and services. The German market for fast food: outlook: trends to watch
- Abstracts: The German market for textile washing products: company profiles: Colgate-Palmolive GmbH
- Abstracts: The Spanish market for hair care: distribution: retail: washing products. The Spanish market for hair care: distribution: retail styling products
- Abstracts: How Canadian Tire refocused and solved its identitity crisis. Bay readies its Outfitters chain
- Abstracts: Beefier ads on the BIC menu for 1999. Rogers aims for unified brand image. Wild, wacky and kool